Foundation Medicine Files to go Public with an Offering of up to $86.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer genomics firm Foundation Medicine has filed to go public, with a target goal of raising as much as $86.3 million.

The Cambridge, Mass.-based firm has not yet priced its shares or said how many shares it plans to offer in its initial public offering. It plans to list on the Nasdaq under ticker symbol "FMI".

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.